News
IOBT
0.8290
-3.93%
-0.0339
Weekly Report: what happened at IOBT last week (0106-0110)?
Weekly Report · 2d ago
IO Biotech completes enrollment in Phase 2 trial of IO102-IO103
TipRanks · 5d ago
IO BIOTECH INC - INITIAL DATA FROM PHASE 2 TRIAL EXPECTED IN 2025
Reuters · 5d ago
IO Biotech Completes Enrollment in Phase 2 Trial of its Investigational, Off-the-shelf Therapeutic Cancer Vaccine, IO102-IO103, as Neoadjuvant/Adjuvant Treatment for Patients with Resectable Melanoma or Head and Neck Cancer
Barchart · 6d ago
Weekly Report: what happened at IOBT last week (1230-0103)?
Weekly Report · 01/06 09:07
Weekly Report: what happened at IOBT last week (1223-1227)?
Weekly Report · 12/30/2024 09:06
IO BIOTECH INC - RECEIVES NASDAQ NOTICE FOR MINIMUM BID PRICE NON-COMPLIANCE
Reuters · 12/27/2024 21:17
Weekly Report: what happened at IOBT last week (1216-1220)?
Weekly Report · 12/23/2024 09:07
IO Biotech announces up to €57.5M debt financing from the European Investment Bank
Seeking Alpha · 12/20/2024 20:16
IO Biotech Secures €57.5 Million EIB Loan Facility
TipRanks · 12/20/2024 13:27
IO Biotech secures up to EUR 57.5M in debt financing
TipRanks · 12/20/2024 13:15
IO BIOTECH INC: DEBT FACILITY EXPECTED TO EXTEND COMPANY'S CASH RUNWAY INTO Q2 OF 2026
Reuters · 12/20/2024 13:05
IO Biotech secures up to €57.5 million in debt financing from the European Investment Bank
Barchart · 12/20/2024 07:05
Here's Why We're A Bit Worried About IO Biotech's (NASDAQ:IOBT) Cash Burn Situation
Simply Wall St · 12/17/2024 11:12
Weekly Report: what happened at IOBT last week (1209-1213)?
Weekly Report · 12/16/2024 09:07
Weekly Report: what happened at IOBT last week (1202-1206)?
Weekly Report · 12/09/2024 09:07
Weekly Report: what happened at IOBT last week (1125-1129)?
Weekly Report · 12/02/2024 09:07
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 11/29/2024 21:06
Weekly Report: what happened at IOBT last week (1118-1122)?
Weekly Report · 11/25/2024 09:06
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 11/22/2024 21:06
More
Webull provides a variety of real-time IOBT stock news. You can receive the latest news about Io Biotech, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About IOBT
IO Biotech Inc is a clinical-stage biopharmaceutical company developing immune-modulating cancer therapies based on T-win technology platform. The Company’s product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. IO Biotech’s lead product candidate, IO102-IO103, is designed to target the immunosuppressive mechanisms mediated by key immunosuppressive proteins such as IDO and PD-L1. The Company develops a pipeline of product candidates that leverage its T-win technology platform to address targets within the TME. The Company is spin-off of National Cancer for Center Immune Therapy at Herlev University Hospital in Denmark.